Eramo et al. (2008) and Tirino et al. (2009) identified a lung CSC subpopulation among CD133-expressing cancer cells; moreover, these cells were shown to be capable of generating tumor xenografts, acquiring specific linear markers upon differentiation and escaping chemotherapy-induced apoptosis. This evidence concerns the gene PROM1 and cancer.